Curariform antagonists bind in different orientations to the nicotinic receptor ligand binding domain

Hai Long Wang, Fan Gao, Nina Bren, Steven M Sine

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Curariform alkaloids competitively inhibit muscle acetylcholine receptors (AChR) by bridging the α and non-α subunits that form the ligand-binding site. Here we delineate bound orientations of d-tubocurarine (d-TC) and its methylated derivative metocurine using mutagenesis, ligand binding measurements, and computational methods. When tested against a series of lysine mutations in the ε subunit, the two antagonists show marked differences in the consequences of the mutations on binding affinity. The mutations εL117K, εY111K, and εL109K decrease affinity of metocurine by up to 3 orders of magnitude but only slightly alter affinity of d-TC. At the α subunit face of the binding site, the mutation αY198T decreases affinity of both antagonists, but αY198F preferentially enhances affinity of d-TC. Computation of antagonist docking orientations, based on our structural model of the α-ε site of the human AChR, indicates distinct orientations of each antagonist; the flatter metocurine fits into a pocket formed principally by the ε subunit, whereas the more compact d-TC spans the narrower crevasse between α and ε subunits. The side chains of εTyr-111 and εThr-117 juxtapose one of two quaternary nitrogens in metocurine but are remote from the equivalent quaternary nitrogen in d-TC, which instead closely approaches αTyr-198. The different docked orientations arise through tilt of the curariform scaffold by ∼60° normal to the nitrogen-nitrogen axis, together with a 20° rotation about the axis. The overall mutagenesis and computational results show that despite their similar structures, d-TC and metocurine bind in distinctly different orientations to the adult human AChR.

Original languageEnglish (US)
Pages (from-to)32284-32291
Number of pages8
JournalJournal of Biological Chemistry
Volume278
Issue number34
DOIs
StatePublished - Aug 22 2003

Fingerprint

Tubocurarine
Nicotinic Receptors
Ligands
Cholinergic Receptors
Nitrogen
Mutagenesis
Mutation
Binding Sites
Structural Models
Computational methods
Alkaloids
Scaffolds
Lysine
Muscle
metocurine
Derivatives
Muscles

ASJC Scopus subject areas

  • Biochemistry

Cite this

Curariform antagonists bind in different orientations to the nicotinic receptor ligand binding domain. / Wang, Hai Long; Gao, Fan; Bren, Nina; Sine, Steven M.

In: Journal of Biological Chemistry, Vol. 278, No. 34, 22.08.2003, p. 32284-32291.

Research output: Contribution to journalArticle

@article{1a63b455d3db430bbce9160717b448d3,
title = "Curariform antagonists bind in different orientations to the nicotinic receptor ligand binding domain",
abstract = "Curariform alkaloids competitively inhibit muscle acetylcholine receptors (AChR) by bridging the α and non-α subunits that form the ligand-binding site. Here we delineate bound orientations of d-tubocurarine (d-TC) and its methylated derivative metocurine using mutagenesis, ligand binding measurements, and computational methods. When tested against a series of lysine mutations in the ε subunit, the two antagonists show marked differences in the consequences of the mutations on binding affinity. The mutations εL117K, εY111K, and εL109K decrease affinity of metocurine by up to 3 orders of magnitude but only slightly alter affinity of d-TC. At the α subunit face of the binding site, the mutation αY198T decreases affinity of both antagonists, but αY198F preferentially enhances affinity of d-TC. Computation of antagonist docking orientations, based on our structural model of the α-ε site of the human AChR, indicates distinct orientations of each antagonist; the flatter metocurine fits into a pocket formed principally by the ε subunit, whereas the more compact d-TC spans the narrower crevasse between α and ε subunits. The side chains of εTyr-111 and εThr-117 juxtapose one of two quaternary nitrogens in metocurine but are remote from the equivalent quaternary nitrogen in d-TC, which instead closely approaches αTyr-198. The different docked orientations arise through tilt of the curariform scaffold by ∼60° normal to the nitrogen-nitrogen axis, together with a 20° rotation about the axis. The overall mutagenesis and computational results show that despite their similar structures, d-TC and metocurine bind in distinctly different orientations to the adult human AChR.",
author = "Wang, {Hai Long} and Fan Gao and Nina Bren and Sine, {Steven M}",
year = "2003",
month = "8",
day = "22",
doi = "10.1074/jbc.M304366200",
language = "English (US)",
volume = "278",
pages = "32284--32291",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "34",

}

TY - JOUR

T1 - Curariform antagonists bind in different orientations to the nicotinic receptor ligand binding domain

AU - Wang, Hai Long

AU - Gao, Fan

AU - Bren, Nina

AU - Sine, Steven M

PY - 2003/8/22

Y1 - 2003/8/22

N2 - Curariform alkaloids competitively inhibit muscle acetylcholine receptors (AChR) by bridging the α and non-α subunits that form the ligand-binding site. Here we delineate bound orientations of d-tubocurarine (d-TC) and its methylated derivative metocurine using mutagenesis, ligand binding measurements, and computational methods. When tested against a series of lysine mutations in the ε subunit, the two antagonists show marked differences in the consequences of the mutations on binding affinity. The mutations εL117K, εY111K, and εL109K decrease affinity of metocurine by up to 3 orders of magnitude but only slightly alter affinity of d-TC. At the α subunit face of the binding site, the mutation αY198T decreases affinity of both antagonists, but αY198F preferentially enhances affinity of d-TC. Computation of antagonist docking orientations, based on our structural model of the α-ε site of the human AChR, indicates distinct orientations of each antagonist; the flatter metocurine fits into a pocket formed principally by the ε subunit, whereas the more compact d-TC spans the narrower crevasse between α and ε subunits. The side chains of εTyr-111 and εThr-117 juxtapose one of two quaternary nitrogens in metocurine but are remote from the equivalent quaternary nitrogen in d-TC, which instead closely approaches αTyr-198. The different docked orientations arise through tilt of the curariform scaffold by ∼60° normal to the nitrogen-nitrogen axis, together with a 20° rotation about the axis. The overall mutagenesis and computational results show that despite their similar structures, d-TC and metocurine bind in distinctly different orientations to the adult human AChR.

AB - Curariform alkaloids competitively inhibit muscle acetylcholine receptors (AChR) by bridging the α and non-α subunits that form the ligand-binding site. Here we delineate bound orientations of d-tubocurarine (d-TC) and its methylated derivative metocurine using mutagenesis, ligand binding measurements, and computational methods. When tested against a series of lysine mutations in the ε subunit, the two antagonists show marked differences in the consequences of the mutations on binding affinity. The mutations εL117K, εY111K, and εL109K decrease affinity of metocurine by up to 3 orders of magnitude but only slightly alter affinity of d-TC. At the α subunit face of the binding site, the mutation αY198T decreases affinity of both antagonists, but αY198F preferentially enhances affinity of d-TC. Computation of antagonist docking orientations, based on our structural model of the α-ε site of the human AChR, indicates distinct orientations of each antagonist; the flatter metocurine fits into a pocket formed principally by the ε subunit, whereas the more compact d-TC spans the narrower crevasse between α and ε subunits. The side chains of εTyr-111 and εThr-117 juxtapose one of two quaternary nitrogens in metocurine but are remote from the equivalent quaternary nitrogen in d-TC, which instead closely approaches αTyr-198. The different docked orientations arise through tilt of the curariform scaffold by ∼60° normal to the nitrogen-nitrogen axis, together with a 20° rotation about the axis. The overall mutagenesis and computational results show that despite their similar structures, d-TC and metocurine bind in distinctly different orientations to the adult human AChR.

UR - http://www.scopus.com/inward/record.url?scp=0042357059&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042357059&partnerID=8YFLogxK

U2 - 10.1074/jbc.M304366200

DO - 10.1074/jbc.M304366200

M3 - Article

C2 - 12799358

AN - SCOPUS:0042357059

VL - 278

SP - 32284

EP - 32291

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 34

ER -